Agilent Technologies, Inc. (ETR:AG8)
Germany · Delayed Price · Currency is EUR | Market Cap | 35.69B +18.9% |
| Revenue (ttm) | 6.41B +8.6% |
| Net Income | 1.25B +18.0% |
| EPS | 4.41 +18.4% |
| Shares Out | n/a |
| PE Ratio | 28.51 |
| Forward PE | 22.32 |
| Dividend | 0.87 (0.70%) |
| Ex-Dividend Date | Jun 30, 2026 |
| Volume | n/a |
| Open | 123.65 |
| Previous Close | 123.10 |
| Day's Range | 123.65 - 125.65 |
| 52-Week Range | 109.85 - 136.65 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 26, 2026 |
About Agilent Technologies
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti... [Read more]
Financial Performance
In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.
Financial numbers in USD Financial StatementsNews
Agilent to Participate in J.P. Morgan U.S. All Stars Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the J.P. Morgan U.S. Al...
Agilent assumed with a Neutral at UBS
UBS assumed coverage of Agilent (A) with a Neutral rating and $165 price target Organic growth has recovered and should support 6% revenue and 10%+ EPS growth in FY27, but…
Agilent announces retirement of board chair Koh Boon Hwee
Agilent (A) Technologies announced that Koh Boon Hwee, independent chair of the company’s board of directors, retired from the board effective Sept. 4, 2026, following more than two decades of…
Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company's board of directors, retired from the board effective Se...
Agilent announces U.S. launch of Agilent S540MD Slide Scanner System
Agilent (A) Technologies announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging digital scanner, following FDA clearance. The company said, “Engineered for speed a...
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, follo...
Agilent quarterly filing raises questions, says Jefferies
Jefferies says Agilent’s (A) fiscal Q3 filing includes color that described a significant decline for its liquid chromatography-mass spectrometry equipment in America while Europe also saw declines. T...
Agilent announces launch of Agilent Cary 635 FTIR spectrometer
Agilent (A) Technologies announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fourier transform infrared analysis. The company said, “Co...
Agilent Introduces the Cary 635 FTIR Spectrometer
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fo...
Agilent price target raised to $180 from $160 at Wells Fargo
Wells Fargo raised the firm’s price target on Agilent (A) to $180 from $160 and keeps an Overweight rating on the shares. The company’s Q3 beat and guidance raise reflects…
Agilent price target raised to $175 from $150 at Barclays
Barclays analyst Luke Sergott raised the firm’s price target on Agilent (A) to $175 from $150 and keeps an Overweight rating on the shares. The firm updated the company’s model…
Agilent price target raised to $185 from $155 at RBC Capital
RBC Capital raised the firm’s price target on Agilent (A) to $185 from $155 and keeps an Outperform rating on the shares after its Q3 earnings beat and guidance raise.
Agilent price target raised to $180 from $155 at TD Cowen
TD Cowen analyst Dan Brennan raised the firm’s price target on Agilent (A) to $180 from $155 and keeps a Buy rating on the shares. The firm said they posted…
Agilent price target raised to $172 from $148 at Evercore ISI
Evercore ISI analyst Vijay Kumar raised the firm’s price target on Agilent (A) to $172 from $148 and keeps an Outperform rating on the shares.
Agilent price target raised to $180 from $155 at Bernstein
Bernstein raised the firm’s price target on Agilent (A) to $180 from $155 and keeps an Outperform rating on the shares. The firm notes Agilent reported a Q3 beat and…
Agilent price target raised to $180 from $155 at Bernstein
Bernstein raised the firm’s price target on Agilent (A) to $180 from $155 and keeps an Outperform rating on the shares. The firm notes Agilent reported a Q3 beat and…
Agilent price target raised to $190 from $180 at JPMorgan
JPMorgan raised the firm’s price target on Agilent (A) to $190 from $180 and keeps an Overweight rating on the shares. The company reported a Q3 beat driven by an…
Agilent price target raised to $175 from $155 at Goldman Sachs
Goldman Sachs analyst Evie Koslosky raised the firm’s price target on Agilent (A) to $175 from $155 and keeps a Buy rating on the shares. The China recovery and advanced…
Agilent price target raised to $190 from $185 at Citi
Citi analyst Patrick Donnelly raised the firm’s price target on Agilent (A) to $190 from $185 and keeps a Buy rating on the shares. The firm upped the company’s estimates…
Agilent price target raised to $180 from $170 at Stifel
Stifel analyst Daniel Arias raised the firm’s price target on Agilent (A) to $180 from $170 and keeps a Buy rating on the shares. Agilent’s Q3 beat “probably won’t surprise…
Agilent price target raised to $180 from $155 at BofA
BofA analyst Michael Ryskin raised the firm’s price target on Agilent (A) to $180 from $155 and keeps a Buy rating on the shares. The set-up into FY27 continues to…
Agilent raises annual profit forecast on improving lab tools demand
Agilent Technologies raised its annual profit forecast on Wednesday, betting on improving demand for its medical tools and equipment used in lab research and drug development.
Agilent Technologies Earnings Call Transcript: Q3 2026
Q3 delivered strong revenue and EPS growth, exceeding guidance, with robust performance in pharma, advanced therapeutics, and China. FY26 guidance was raised for revenue and EPS, supported by innovation, operational execution, and strong end-market trends.
Agilent Technologies Earnings release: Q3 2026
Agilent Technologies released its Q3 2026 earnings on August 26, 2026, summarizing the period's financial results.
Agilent Technologies Slides: Q3 2026
Agilent Technologies has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on August 26, 2026.